UTILITY Therapeutics
Nina Aabenhus Kromann is the Acting Head of CMC at UTILITY therapeutics.
Nina is specialised within CMC with more than 20 years’ experience in the pharmaceutical industry, spanning roles in research, development, QC, regulatory CMC and management. Nina acts as senior CMC specialist as well as Head of CMC. She has extensive experience within both small molecules and biologics and has worked with CMC of antibiotics for the last 5 years. She brings significant experience in all aspects of CMC as well as relations to the CMOs.
Nina holds a Master’s Degree in Biology from University of Copenhagen and has experience from pharmaceutical companies Novo Nordisk, LEO Pharma, ALK-Abelló and Jacobsen Pharma and MedTech Advice.
This person is not in any teams
This person is not in any offices
UTILITY Therapeutics
UTILITY Therapeutics Ltd., is a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI), to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections.